Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
Bisimwa BC, Nachega JB, Warren RM, Theron G, Metcalfe JZ, Shah M, Diacon AH, Sam-Agudu NA, Yotebieng M, Bulabula ANH, Katoto PDMC, Chirambiza JP, Nyota R, Birembano FM, Musafiri EM, Byadunia S, Bahizire E, Kaswa MK, Callens S, Kashongwe ZM. Bisimwa BC, et al. Among authors: kaswa mk. Clin Infect Dis. 2021 Jul 15;73(2):e362-e370. doi: 10.1093/cid/ciaa873. Clin Infect Dis. 2021. PMID: 32590841 Free PMC article.
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Bulabula ANH, Nelson JA, Musafiri EM, Machekano R, Sam-Agudu NA, Diacon AH, Shah M, Creswell J, Theron G, Warren RM, Jacobson KR, Chirambiza JP, Kalumuna D, Bisimwa BC, Katoto PDMC, Kaswa MK, Birembano FM, Kitete L, Grobusch MP, Kashongwe ZM, Nachega JB. Bulabula ANH, et al. Among authors: kaswa mk. Clin Infect Dis. 2019 Sep 27;69(8):1278-1287. doi: 10.1093/cid/ciy1105. Clin Infect Dis. 2019. PMID: 30759187 Free PMC article.
Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study.
Kashongwe IM, Mawete F, Mbulula L, Nsuela DJ, Losenga L, Anshambi N, Aloni M, Kaswa M, Kayembe JMN, Umba P, Lepira FB, Kashongwe ZM. Kashongwe IM, et al. PLoS One. 2020 Aug 4;15(8):e0236264. doi: 10.1371/journal.pone.0236264. eCollection 2020. PLoS One. 2020. PMID: 32750060 Free PMC article.
Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl.
Kaswa MK, Aloni M, Nkuku L, Bakoko B, Lebeke R, Nzita A, Muyembe JJ, de Jong BC, de Rijk P, Verhaegen J, Boelaert M, Ieven M, Van Deun A. Kaswa MK, et al. J Clin Microbiol. 2014 Aug;52(8):2876-80. doi: 10.1128/JCM.00398-14. Epub 2014 May 28. J Clin Microbiol. 2014. PMID: 24871222 Free PMC article.
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.
Jouet A, Gaudin C, Badalato N, Allix-Béguec C, Duthoy S, Ferré A, Diels M, Laurent Y, Contreras S, Feuerriegel S, Niemann S, André E, Kaswa MK, Tagliani E, Cabibbe A, Mathys V, Cirillo D, de Jong BC, Rigouts L, Supply P. Jouet A, et al. Among authors: kaswa mk. Eur Respir J. 2021 Mar 18;57(3):2002338. doi: 10.1183/13993003.02338-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 32943401 Free PMC article.
16 results